HSS Physician-in-Chief @HSS_PIC

PIC, Chair of Medicine, Rheumatologist @HSpecialSurgery, Director of Rheumatology @WeillCornell hss.edu New York, NY Joined October 2019

Tweets

271
Followers

524
Following

175
Likes

74

HSS Physician-in-Chief @HSS_PIC

a day ago

The literature was reviewed on necrotizing and non-necrotizing granulomatous reactions in cancer patients treated with immune checkpoint inhibitors by HSS Department of Medicine Researchers and physicians. #HSSRheum pubmed.ncbi.nlm.nih.gov/40664481/5

0 1 2 227 0

HSS Physician-in-Chief @HSS_PIC

3 days ago

A novel regulatory axis, with opposing regulation of TNF responses by IFN-γ and PGE2, in rheumatoid and immune checkpoint inhibitor-induced arthritis, was presented by multiple HSS authors, with senior author Lionel B. Ivashkiv, MD. #HSSRheum pubmed.ncbi.nlm.nih.gov/40662950/

0 2 2 310 0

HSS Physician-in-Chief @HSS_PIC

6 days ago

Patients with antiphospholipid antibodies who were ANA+ showed higher rates of systemic autoimmune features, including hematologic manifestations, lower complement levels, ENA positivity, and joint involvement, reported Doruk Erkan, MD, MPH. pubmed.ncbi.nlm.nih.gov/39423147/

0 1 1 272 0

HSS Physician-in-Chief @HSS_PIC

a week ago

Apremilast may be useful in treating immune checkpoint inhibitor-induced psoriasis (less so in psoriatic arthritis), reported Kyle Ge, Nilasha Ghosh, MD, MS, RhUSMS, and Anne R. Bass, MD. #HSSRheum acrjournals.onlinelibrary.wiley.com/doi/abs/10.100…

1 1 2 358 0

HSS Physician-in-Chief @HSS_PIC

a week ago

In last week's grand rounds, Ivona Aksentijevich, MD, presented “Expanding the genetic & clinical spectrum of autoinflammatory diseases,” elucidating how rare mutations, common risk alleles, somatic variants, & environment together shape autoimmunity & autoinflammatory diseases.

0 1 0 264 1

Download Image

HSS Physician-in-Chief @HSS_PIC

a week ago

In the following review by Mary K. Crow, MD, Type I Interferons in both health and disease, including their molecular aspects and clinical implications, both as mediators and therapeutic targets. #HSSRheum pubmed.ncbi.nlm.nih.gov/40637491/

0 1 1 239 0

HSS Physician-in-Chief @HSS_PIC

2 weeks ago

Your patients are invited to join a free live interactive seminar on research on pain and fatigue in rheumatoid arthritis on 9/15/25 at 7 PM EDT with Susan Goodman MD and Charis Meng MD. #HSSRheum hss.zoom.us/webinar/regist…

0 0 1 123 1

HSS Physician-in-Chief @HSS_PIC

2 weeks ago

In systemic sclerosis patients, sexual dysfunction is not adequately screened for by rheumatologists or existing screening tools, noted HSS Department of Medicine researchers and physicians. #HSSRheum pubmed.ncbi.nlm.nih.gov/40727418/

0 1 4 440 0

Hospital for Special Surgery (HSS) @HSpecialSurgery

2 weeks ago

Jessica K. Gordon, MD, rheumatologist at HSS, joins Mogil's MobCast: A Scleroderma Chat where she explores scleroderma, covering the 3 stages of skin progression, treatment options, and Raynaud’s phenomenon. podcasts.apple.com/us/podcast/epi… #HSSRheum

0 1 3 235 0

HSS Physician-in-Chief @HSS_PIC

2 months ago

Dr. Anne Bass reported on imaging in immune checkpoint-inhibitor-induced arthritis, noting that when inflammatory, arthritis can be peripheral vs polymyalgia rheumatica-like. #HSSRheum thelancet.com/journals/lanrh…

1 0 5 100 0

HSS Physician-in-Chief @HSS_PIC

2 months ago

Drs. Russell, Ashany, Stein and Goodman followed ankylosing spondylitis patients with HR-pQCT after starting secukinumab, finding no substantial change in bone mineral density and microarchitecture at 24 months. #HSSRheum pubmed.ncbi.nlm.nih.gov/40481972/

0 1 4 136 0

HSS Physician-in-Chief @HSS_PIC

2 months ago

Drs. Medha Barbhaiya, Doruk Erkan, Michael Lockshin and Deanna Jannat-Khah reported on developing the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria focused on the derivation cohort and definition refinement. #HSSRheum doi.org/10.1002/acr.25…

0 1 6 158 0

Hospital for Special Surgery (HSS) @HSpecialSurgery

2 months ago

HSS has been ranked No. 1 in the nation for orthopedics for a record-breaking 16th consecutive year and No. 3 in the nation for rheumatology by @usnews 2025-2026 Best Hospitals: Specialty Rankings. news.hss.edu/hss-ranked-no-…

9 17 32 4K 3

Download Image

Hospital for Special Surgery (HSS) @HSpecialSurgery

2 months ago

Recently, HSS rheumatologists Jessica K. Gordon, MD, MS, and Kim (Showalter) Lakin, MD, MS, attended the 2025 National Scleroderma Foundation Patient Conference in St Louis, MO. During the conference, which provides an inclusive educational event for anyone impacted by…

0 1 3 558 0

Download Image

HSS Physician-in-Chief @HSS_PIC

2 months ago

Dr. Lauren Robinson reported on innate immunity in lupus, emphasizing toll-like receptor signaling, NLRP3 inflammasome activation, myeloid cell dysregulation, and microbiome-immune interactions. #HSSRheum doi.org/10.1093/hmg/dd…

0 1 1 390 0

HSS Physician-in-Chief @HSS_PIC

2 months ago

Drs. Jessica Gordon and Kimberly Lakin reported that puffy fingers and hands, without Raynaud’s phenomenon, occurred in >30% of systemic sclerosis (SSc) patients, suggesting SSc testing, especially RNA polymerase III. #HSSRheum pubmed.ncbi.nlm.nih.gov/40386907/

0 1 1 308 0

HSS Physician-in-Chief @HSS_PIC

2 months ago

Dr. Vivian Bykerk (@BykerkVivian) reported that, looking at steady-state abatacept (ABA) concentrations, no increase in the risk of first infection was found, regardless of ABA exposure level, in patients with RA receiving subcutaneous ABA. #HSSRheum pubmed.ncbi.nlm.nih.gov/39814436/